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Isolation of Angola-like Marburg virus from
Egyptian rousette bats from West Africa
Brian R. Amman1, Brian H. Bird2, Ibrahim A. Bakarr3, James Bangura2,4, Amy J. Schuh1, Jonathan Johnny3,
Tara K. Sealy1, Immah Conteh3, Alusine H. Koroma3, Ibrahim Foday3, Emmanuel Amara4, Abdulai A. Bangura4,
Aiah A. Gbakima5, Alexandre Tremeau-Bravard3, Manjunatha Belaganahalli3, Jasjeet Dhanota2, Andrew Chow2,
Victoria Ontiveros2, Alexandra Gibson2, Joseph Turay4, Ketan Patel1, James Graziano1, Camilla Bangura3,
Emmanuel S. Kamanda3, Augustus Osborne3, Emmanuel Saidu3, Jonathan Musa3, Doris Bangura3,
Samuel Maxwell Tom Williams3, Richard Wadsworth3, Mohamed Turay4, Lavalie Edwin4,
Vanessa Mereweather-Thompson4, Dickson Kargbo4, Fatmata V. Bairoh4, Marilyn Kanu4, Willie Robert4,
Victor Lungai4, Raoul Emeric Guetiya Wadoum4, Moinya Coomber4, Osman Kanu4, Amara Jambai6,
Sorie M. Kamara7, Celine H. Taboy1, Tushar Singh8, Jonna A.K. Mazet2, Stuart T. Nichol1, Tracey Goldstein 2*,
Jonathan S. Towner 1* & Aiah Lebbie 3*
Marburg virus (MARV) causes sporadic outbreaks of severe Marburg virus disease (MVD).
Most MVD outbreaks originated in East Africa and field studies in East Africa, South Africa,
Zambia, and Gabon identified the Egyptian rousette bat (ERB; Rousettus aegyptiacus) as a
natural reservoir. However, the largest recorded MVD outbreak with the highest case–fatality
ratio happened in 2005 in Angola, where direct spillover from bats was not shown. Here,
collaborative studies by the Centers for Disease Control and Prevention, Njala University,
University of California, Davis USAID-PREDICT, and the University of Makeni identify MARV
circulating in ERBs in Sierra Leone. PCR, antibody and virus isolation data from 1755 bats of
42 species shows active MARV infection in approximately 2.5% of ERBs. Phylogenetic
analysis identifies MARVs that are similar to the Angola strain. These results provide evi-
dence of MARV circulation in West Africa and demonstrate the value of pathogen surveil-
lance to identify previously undetected threats.
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Marburg virus (MARV), a close relative of the better-known Ebola virus (EBOV), is the founding member ofthe family Filoviridae1,2 and is known to cause sporadic
outbreaks of severe, often fatal disease in humans. There have
been 12 known Marburg virus disease (MVD) outbreaks, most
recently in 2017 in Uganda3,4. The largest MVD outbreak on
record occurred in Uige, Angola, in 2005, with 227 deaths out of
252 known cases5. This was the highest case-fatality ratio (CFR:
90%) recorded for any large filovirus outbreak, including the
2013–2016 Ebola virus outbreak in West Africa (CFR: 41%,)6. A
direct link to MARV spillover from bats was not made during the
event in Angola. Consistent with the high CFR during the out-
break in Angola, the MARV Angola strain appears to be sig-
nificantly more virulent than all other MARV strains (Musoke,
Ravn, and Ozolin) in experimentally infected non-human
primates7,8. The Angola outbreak was the only MVD outbreak
to originate outside of East Africa; all previous MVD outbreaks
occurred in, or originated from, Uganda, Kenya, Democratic
Republic of the Congo (DRC), or South Africa ex Zimbabwe9,10.
Other filoviruses circulating in Africa include the marburgvirus,
Ravn virus (RAVV), as well as five ebolaviruses, EBOV, Sudan
virus (SUDV), Tai Forest virus (TAFV), Bundibugyo virus
(BDBV), and the recently discovered Bombali virus (BOMV)9,11.
Extensive field studies in Uganda12–14, DRC10, Kenya15, South
Africa16, Gabon17,18, and Zambia19,20, as well as experimental
infection studies in captive bats in the United States21,22 and
South Africa23,24, have shown that the cave-dwelling Egyptian
rousette bat (ERB; Rousettus aegyptiacus) is a primary natural
reservoir of MARV. This discovery is consistent with the origins
of MVD outbreaks that, when known, have been linked to caves
or mines, with MARV most often having spilled over to miners
who work underground in known ERB roosting sites, and occa-
sionally to tourists who viewed ERBs too closely25–28. Infected
ERBs shed MARV in saliva and urine, and the virus can persist
for weeks in various tissues, particularly liver, spleen, and lymph
nodes21,22. Under experimental conditions, MARV can be
transmitted directly between ERBs in the absence of arthropod
vectors. Furthermore, some infected bats appear to be super-
shedders, capable of shedding a disproportionate amount of virus,
leading to increased bat-bat transmission in accordance with the
Pareto principle22. To date, arthropod vectors do not appear to
contribute to natural enzootic transmission of MARV among
ERBs10,29–33.
In equatorial Africa, ERBs live in very large, dense colonies
sometimes numbering over 100,000 bats14. They can breed twice
a year, producing thousands of susceptible juvenile bats every six
months in a single ERB roost12,34. Field studies in Uganda
showed that 2–3% of all ERBs are actively infected with mar-
burgviruses (MARV and RAVV) at any one time and that
infection levels spike biannually, up to 12% on average, in juvenile
bats. Importantly, these seasonal spikes appear to be associated
with increased risk of human exposure, as they coincide with
>84% of known MARV spillover events to humans12. Despite the
linkage of ERBs to human MVD outbreaks, attempts to mitigate
risk through bat extermination were counterproductive and led to
increased levels of active MARV infection in the recolonizing bat
population13.
Since 2007, over 80 distinct MARV genomic sequences and
21 virus isolates have been obtained from tissues of infected
wild-caught ERBs, representing every major MARV strain
found in MVD outbreaks since 1967, with the exception of the
Angola strain9. In Gabon, South Africa and Zambia, MARV
was detected in ERBs despite no known associated human
MVD outbreaks in the country16–20. Here, through a combined
multi-institutional effort, we report the presence of MARV,
including an Angola-like MARV, in ERBs in West Africa.
Importantly, no MVD outbreaks have been reported in Sierra
Leone despite the presence of MARV. Our findings highlight
the value of engaging with all stakeholders with appropriate
messaging that identify and mitigate pathogens of public health
concern before recognized spillovers occur. This is in consonant
with measures that ensure animal and environmental health.
Moreover, it underpins the One Health surveillance approach
that recognizes the interconnected relationship between
people and other organisms (plants and animals) in a shared
environment.
Results
Marburg virus detection and isolation. A total of 1755 bats from
42 species were captured and sampled from 4 districts in Sierra
Leone: Moyamba (Kasewe Cave: 8°19'26.80“N, 12°10′36.00“W),
Kailahun (Tailu Village: 8°18'27.18“N, 10°30′55.32“W), Koinadugu
(Kakoya Cave: 9°41′24.00“N, 11°40′12.00“W), and Kono (Koema
Cave: 8°52′12.00“N, 10°48′36.00“W) (Fig. 1). All bat samples were
tested for 5 filoviruses (EBOV, TAFV, BDBV, MARV, and RAVV).
Of these, 435 bats were identified as ERBs (Kasewe Cave, n= 186;
Tailu Village, n= 7; Kakoya Cave, n= 131; Koema Cave, n = 111),
from which 11 bats (2.5%) tested positive for active MARV infec-
tion by virus-specific real-time RT-PCR or consensus RT-PCR.
MARV-positive samples included six liver/spleen, five lymph nodes,
two oral swabs, one salivary gland, and one whole blood sample
(Table 1). MARV isolation was attempted on all PCR positive tis-
sues (n= 13) and swabs (n= 2), and from those, four virus isolates
were obtained from three ERBs caught at Kasewe Cave. Two
MARV isolates were obtained from one bat (no. 960), one from the
liver/spleen and the other from lymph node, while one isolate
was obtained from two other bats (nos. 968 and 1000), each from
liver/spleen. Owing to a non-destructive sampling protocol, tissue
specimens from ERBs captured at Kakoya and Koema Caves were
not available for similar analysis.
Sequence and phylogenetic analysis. MARV sequences from
small diagnostic NP and VP35 gene fragments were determined
from 10 of the 11 PCR-positive bats using an array of sequencing
approaches, depending on the institution performing the sur-
veillance and sequence analysis. A synopsis of tissue Ct values,
sequences generated, and methodologies used for all qRT-PCR
bats is shown in Supplementary Table 1. These MARV sequences
were then compared by maximum-likelihood phylogenetic ana-
lysis to 128 NP and/or VP35 sequence fragments obtained pre-
viously from ERBs or humans in Uganda, DRC, Angola, Gabon,
and Kenya. The phylogenetic analysis shows that the Sierra
Leone-derived MARV sequences are most closely related to
sequences obtained in Gabon and Angola (Fig. 2). In addition,
MARV full-length genome sequences were determined by gen-
ome walking of MARV RNA extracted from oral swabs and
whole blood (n= 2), one of which was phylogenetically similar to
the Angola-like MARV isolates (n= 4) (Fig. 3). Genetic simila-
rities between sequences are shown in Supplementary Tables 2–9.
Unexpectedly, MARV isolate sequences from bats nos. 960 (n=
2), 968, and 1000 were 100% identical across the full-length virus
genome. To rule out cross-contamination during virus isolation,
RNA was extracted directly from ERB tissues and approximately
5 kb of MARV RNA was sequenced using an Angola strain-
specific tiling and amplification approach. As with the MARV
isolate sequences, all tissue-derived MARV sequences from those
three bats were 100% identical.
Marburg virus infection demographics and serology. Among
the 193 ERBs captured at Kasewe Cave and Tailu Village, 140
(72.5%) were juveniles (forearm length <90 mm; Mutere 1968),
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and 53 (27.5%) were adults. All of the MARV PCR-positive
Kasewe Cave ERBs (9/186) were classified as juveniles (4.8%). A
total of 242 ERBs were sampled at Kakoya and Koema Caves. Of
these, 87 (36%) were juveniles and 155 (64%) were adults. Like
the Kasewe Cave and Tailu Village sites, all MARV-PCR positive
ERBs (2/242; 0.8%) were juveniles. A significant age bias was
detected among MARV-positive bats; all 11 PCR-positive bats
were juveniles (Pearson’s chi-square; χ2= 10.341, p= 0.001). No
sexual bias with respect to MARV active infection was detected
between male (n= 6) and female (n= 5) PCR-positive bats
(Pearson’s chi-square; χ2= 0.003, p= 0.954).
MARV-specific IgG antibody was detected in 24/140 (17.1%)
ERBs captured at Kasewe Cave (n= 136 serum tested) and Tailu
Village (n= 4 serum tested). Notably, two of these MARV IgG
antibody-positive bats were also positive by qRT-PCR. No sexual
bias was observed in MARV-specific IgG antibody-positive ERBs
(5/49 [10.2%] female; 19/91 [20.9%] male; Pearson’s chi-square;
χ2= 2.555, p= 0.110). Consistent with previous studies of wild-
caught ERBs in Uganda12,14, there was a significant age bias, as
32.4% of adults (12/37) were antibody-reactive to MARV
compared to 11.7% of juveniles (12/103; Pearson’s chi-square;
χ2= 8.277, p= 0.004). Sera from ERBs captured at Kakoya and
Koema Caves were not available for IgG analysis. A summary of
ERB qRT-PCR, virus isolation, and ELISA results by sex and age
class is shown in Supplementary Table 10.
Discussion
In this report, we present evidence of active MARV circulation in
West African ERBs based on PCR, antibody, and virus isolation
data and provide the first report of an Angola-like strain of
MARV since it was first detected in humans in 2005. Importantly,
this discovery occurred prior to any known MVD outbreak in
Sierra Leone and was used to implement evidence-based public
health messaging to at-risk communities about MARV spillover
risk. To accomplish this, a comprehensive One Health commu-
nications approach leveraging the human, animal, and environ-
mental and emergency health sectors within the Ministries of
Health and Sanitation and Agriculture, and Forestry and Food
Security along with other international partners was implemented
across national, district, and local community levels. Through
several engagement meetings with Ministry of Health and Sani-
tation and with several relevant ministries, departments and
agencies, (Ministry of Agriculture Forestry and Food security,
Ministry of Local Government, Ministry of Lands, Ministry of
Mines and Mineral Resources, Environment and Protection
Agency, Office of National Security) over a two-week period,
briefing documents including Marburg factsheets, MVD pre-
paredness, detection and response plans were developed and
presented at a national conference. This resulted in recommen-
dations for public health outreach, with a team comprised of key
stakeholders (government health and agriculture units, uni-
versities, development partners and district and local authorities)
across the capital city and three of the districts (Moyamba, Koi-
nadugu and Kono). This outreach team conducted initial infor-
mation sharing events in each community near the ERB colonies
followed by regular in-person meetings with traditional com-
munity leaders and other local stakeholders to provide key
messages related to virus exposure risks and methods to reduce
contact with bats. Concerns raised by local communities where
bushmeat consumption brings them in contact with bats for
livelihood were noted and discussed, and local perceptions about
bats were explored in developing options for minimizing expo-
sure risks. As an additional national-level public preparedness
measure, MVD has now been included in testing regimens at
national laboratories in Sierra Leone.
Marburgviruses have been found in multiple ERB populations
across sub-Saharan and South Africa9. Though fragmented, the
Njala University
Freetown
Kasewe Cave
n = 186
Guinea
Guinea
Liberia
Kakoya Cave
n = 131
University of Makeni
Tailu Village
n = 7
Koema Cave
n = 111
Fig. 1 Map of Sierra Leone showing bat trapping locations. Enlarged map shows locations of caves where populations of Marburg virus-(MARV) positive
Egyptian rousette bats (ERBs; Rousettus aegyptiacus) were discovered (orange circles). The numbers of ERBs captured at each site are shown below the
cave name. Shown on the map of Africa are locations of MARV discovery in ERBs without an outbreak (blue circles), known MARV outbreaks (yellow
circles), and the fragmented geographic range of the MARV natural reservoir, R. aegyptiacus (orange shaded). Image was adapted from base map provided
by NordNordWest under Creative Commons Attribution-Share Alike 3.0 Germany license https://creativecommons.org/licenses/by-sa/3.0/de/
legalcode.
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geographic range for ERBs extends into West Africa, covering
areas of Liberia, Sierra Leone, and Guinea that contain fruiting
trees and caves35. Therefore, finding 11 MARV positive ERBs
from three separate districts (Moyamba, Koinadugu, and Kono)
in Sierra Leone is not unexpected, and together with previous
field studies10,12–14,16 supports the evidence that ERBs are the
primary MARV natural reservoir. The finding of multiple and
diverse MARV genetic lineages simultaneously circulating in
geographically distinct locations in Sierra Leone suggests that
MARV has been present in West Africa for an extended period of
time and is not a recent introduction from other areas of
Africa10,12–14. Indirect fluorescent antibody data suggested that
human MARV infections may have occurred and gone unrec-
ognized in Liberia in the late 1970s, yet due to specificity issues
with the indirect immunofluorescence antibody test at that time,
the significance of the findings were unclear36. Nevertheless, the
isolation of genetically identical viruses from 3/9 bats caught at
the same cave (Kasewe Cave) was surprising. Of note, all three
infected juvenile bats were caught at approximately the same time
(within a day of each other). During similar MARV surveillance
activities in Uganda from 2007–2012, 21 genetically distinct
marburgviruses, including RAVV, were isolated directly from
ERBs12,14, but none were genetically identical to another. In
Sierra Leone, we suspect that finding two or more bats simulta-
neously infected with the same MARV lineage is a consequence of
being infected from a single point source, perhaps a super-
shedder ERB22 interacting with other bats in a small colony.
Moreover, juvenile bats are known to roost together in caves12, a
behavior that may facilitate bat-to-bat transmission from infected
to susceptible individuals. In addition, the field teams did not
observe evidence of massive ERB colonies at Kasewe, Kakoya, and
Koema Caves like those seen in East Africa making multiple
infections stemming from one source more likely. The determi-
nation that the ERB colonies are comparatively small is based on
the lack of widespread fecal deposits on vegetation near the col-
ony entrances, unlike the copious amounts normally seen in East
African ERB populations. Future investigations will include
mark-recapture studies to better estimate population sizes at these
locations. Overall, the presence of the ERB natural reservoir
throughout portions of sub-Saharan Africa implies that mar-
burgviruses could be present in bat populations in many localities
with suitable habitat for this species even though no MVD out-
breaks have yet been recorded.
The MARV infection data from the four capture sites indicates
an age bias towards juvenile ERBs that is consistent with previous
studies in Uganda and South Africa12,16. Overall, more juveniles
were actively infected with MARV, while more adults had anti-
body reactive to MARV. As with Uganda and South Africa, this is
indicative of juveniles having maternal antibody for the first few
months after birth, providing protection against MARV infection.
That antibody eventually wanes, leaving the older (4-6 months)
juvenile cohort susceptible to infection. As the bats get older, the
chances of having been infected with MARV increase, leading to
the increased prevalence of MARV-specific antibody detected in
the adults.
The MARV phylogeny shows that sequences obtained from
ERBs in Sierra Leone align most closely with viruses previously
found in ERBs in Gabon and DRC from 2006–2009, and in
humans in Angola in 2005. The detection of an Angola-like strain
is noteworthy because this is the first time it has been identified in
ERBs even though all other major marburgvirus lineages,
including RAVV, have been detected co-circulating in a single
ERB population in Uganda12–14 or DRC10. In that context, the
overall genetic diversity detected to date in the West African
MARV sequences is comparatively lower and may be a con-
sequence of smaller colony sizes compounded by long-term
immunity in previously infected bats. Experimental infection
studies of captive ERBs have shown that bats retain immunity to
MARV reinfection for up to two years despite diminished anti-
body levels, suggesting that reinfection is not a major driver of
virus persistence in the population37. This type of infection
dynamic in ERBs would further limit the number of susceptible
bat hosts within a colony, thereby potentially limiting the number
of virus strains that can co-circulate within an ERB roost. The fact
Table 1 Summary of MARV infected tissues sampled from Rousettus aegyptiacus in Sierra Leone.
Collection Location—district Bat No. Species Sex Age status Sample type MARV
sequence
Virus isolated
Oct. 2017 Kasewe—
Moyamba
343 R. aegyptiacus M Juv LN Yes No
Oct. 2017 Kasewe—
Moyamba
345 R. aegyptiacus M Juv Liv/Spl Yes No
Oct. 2017 Kasewe—
Moyamba
417 R. aegyptiacus F Juv LN Yes No
Sept. 2018 Kasewe—
Moyamba
940 R. aegyptiacus M Juv LN Yes No
Sept. 2018 Kasewe—
Moyamba
942 R. aegyptiacus M Juv Liv/SplLN No No
Sept. 2018 Kasewe—
Moyamba
960 R. aegyptiacus F Juv Liv/Spl, LN, SG Yes Yes (Liv/
Spl, LN)
Sept. 2018 Kasewe—
Moyamba
965 R. aegyptiacus F Juv Liv/Spl Yes No
Sept. 2018 Kasewe—
Moyamba
968 R. aegyptiacus F Juv Liv/Spl Yes Yes
Sept. 2018 Kasewe—
Moyamba
1000 R. aegyptiacus M Juv Liv/Spl Yes Yes
Dec. 2017 Kakoya—
Koinadugu
3960 R. aegyptiacus F Juv OS, blood Yes No
Dec. 2017 Koema—Kono 4104 R. aegyptiacus F Juv OS Yes No
Juv juvenile, Liv/Spl liver/spleen, LN axillary lymph node, SG salivary gland, OS oral swab
Location and characteristics of Rousettus aegyptiacus infected with MARV captured in three locations in Sierra Leone with a summary of tissues sampled. Infection status was determined by qRT-PCR and
cRT-PCR
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Fig. 2 Mid-point rooted, maximum-likelihood phylogeny of 128 partial sequence fragments. Partial and concatenated marburgvirus nucleoprotein (NP)
and viral protein 35 (VP35) gene fragments were obtained from Rousettus aegyptiacus at three locations in Sierra Leone. Horizontal branch lengths are
proportional to the genetic distance between the sequences and the scale at the bottom of the phylogeny indicates the number of nucleotide substitutions
per site. Numbers to the left of the nodes represent percent bootstrap values based on 1000 replicates. Only bootstrap values greater than 50% are shown.
Sequences in orange represent those generated from the bats in Sierra Leone, sequences in blue represent those generated from bats in Uganda and Gabon
and sequences in black represent those generated from human samples. Genbank accession numbers for the Sierra Leone NP and VP35 sequences for all
Kasbat SL 2017 and Kasbat SL 2018 sequences are as follows: MN193419—MN193431. The SLAB3960Kakbat SL 2017and SLAB410Koebat SL 2017 NP/
VP35 sequences were pulled from the full-length marburgvirus genome sequences (Genbank accession: MN258361—MN258362).
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that the MARV strains detected in Sierra Leonean ERBs are most
similar to those seen in other locations on the west coast of Africa
(Gabon and Angola) may be reflective of restricted ERB move-
ment and consistent with isolation of ERB populations in Sierra
Leone from the larger metapopulation of ERBs across most of
central and eastern Africa. One reason for this isolation could be
loss of contiguous habitat through degradation of forested lands
that bridge the gap between the Congo Basin and West Africa38.
The clear and unwavering recommendation by the authors of
this report is for individuals living and working in close proximity
to caves and mines inhabited by ERBs to avoid these bats.
Extermination of a reservoir species as a means of zoonotic
pathogen control has been shown to be ineffective and can result
in higher ratios of active infection13,39,40. In one recent example, a
Ugandan gold mine was sealed and more than 100,000 ERBs
destroyed. Over the course of several years, the bats returned and
the prevalence of MARV infection in the bat population more
than doubled13. This recolonization was soon followed by the
largest human MVD outbreak in Ugandan history, centered in a
nearby town41. These data show that culling bat populations may
lead to increased human health risks and thus should be avoided
as a pathogen control measure. Furthermore, as a frugivorous
species, ERBs play an extremely important ecological role in
forest regeneration by dispersing seeds and facilitating pollination
of the fruiting trees they visit on a nightly basis. The ecological
benefits of bat activity are critical for the survival of the threa-
tened environment in which they live. Tropical forests in Sierra
Leone, Liberia, and Côte d’Ivoire were reported to be most at risk
in terms of vulnerability, exposure, and pressure from agricultural
expansion42. Of those West African countries, Sierra Leone was
identified as having the greatest pressure from population and
income growth resulting in commodity crop expansion and for-
eign land investment42. With reports of existing vegetative cover
in the upper Guinean forests showing losses of nearly 80%43,
ecologically important species like ERBs are crucial to the health
and longevity of this fragile ecosystem. Perhaps identifying ERBs
as the source of MARV in West Africa can serve as a public
deterrent and promote bat avoidance instead of destruction.
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Fig. 3 Mid-point rooted phylogeny of full-length marburgvirus genomes.Maximum-likelihood phylogeny of full-length marburgvirus genomes. Horizontal
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Methods
Bat capture and processing. All of the work described herein was performed as a
collaborative effort between Njala University, the Centers for Disease Control and
Prevention (CDC), the University of Makeni, and the University of California,
Davis (UCD) USAID-PREDICT. All animal sampling was performed with per-
mission from the Ministry of Agriculture, Forestry, and Food Security, with
approval of both the Institutional Animal Care and Use Committees (IACUC) at
the University of California, Davis (protocol number: 16048) and the CDC (pro-
tocol number: 2943AMMMULX). The chiropteran taxonomy used in this manu-
script follows that of Wilson and Reeder (2005)44. Bats were captured at four sites
in the Sierra Leone districts of Moyamba (Kasewe Cave), Kailahun (Tailu Village),
Koinadugu (Kakoya Cave), and Kono (Koema Cave; Fig. 1). Bats at Kasewe Cave
and Tailu Village were captured using mist nets placed at locations around the cave
or in a suitable habitat with natural flyways and corridors. Captured bats were
placed in breathable cotton bags and transported to a site where they were pro-
cessed via complete necropsy45. Captured bats were humanely euthanized under
anesthesia whereupon a cardiac blood sample was obtained. Two oral secretion
samples were taken using synthetic poly-tipped swabs (Fisher Scientific, Grand
Island, NY, USA or Puritan, Guilford, ME, USA), of which one was placed in
virucidal lysis buffer (MagMax; Life Technologies) for PCR analysis and the other
in viral transport media for virus isolation. Full necropsies were performed, and
visceral tissues (liver, spleen, heart, lung, kidney, salivary gland, axillary lymph
node) were collected and either flash frozen in liquid nitrogen for storage or placed
in virucidal lysis buffer for inactivation and PCR analysis. When handling bats, all
personnel wore appropriate personal protective equipment that included dis-
posable gowns, double gloves including bite gloves (if necessary), face shield and
respiratory protection.
Bats at Kakoya and Koema Caves were also captured with mist nets and placed
in cotton bags until sampling11. Samples were collected in duplicate using non-
destructive techniques (venipuncture, oral, and rectal swabs) and placed into viral
transport media, frozen at −80 °C or into virucidal lysis buffer (Trizol; Roche
Diagnostics) for inactivation and PCR analysis. Bat species field identifications
were confirmed using mtDNA barcoding of the cytochrome b and cytochrome
oxidase subunit 1 mitochondrial genes46.
Statistical analyses. All statistical analyses were done using SPSS Statistics v25
(IBM Corp, Armonk, NY). Measurements were taken on distinct samples. The
ecological data collected at the trapping sites were analyzed for age and sex bias
using two-sided Pearson’s chi-squared tests.
Viral detection and sequencing. Tissue and oral swab samples from bats collected
at Kasewe Cave and Tailu Village were analyzed in country at Njala University by
quantitative reverse transcriptase PCR (qRT-PCR) targeting marburgvirus protein
40 (VP40—MBGConTaqM F-1: GGA CCA CTG CTG GCC ATA TC, MBGCon
TaqM R-3Rev-1: GAG AAC ATl TCG GCA GGA AG; Probes: MBG5313-Prb: 56-
FAM-ATC CTA AAC-ZEN-AGG CTT GTC TTC TCT GGG ACT T-3IABkFQ,
MBG5313-PrbRav: 56-FAM-ATC CTG AAT-ZEN-AAG CTC GTC TTC TCT
GGG ACT T-3IABkFQ). Total RNA was extracted from tissue and oral swabs. RNA
from tissues, approximately 100mg of tissue was placed in 2 mL grinding vials (OPS
Diagnostics, Lebanon, NJ, USA) with 1mL of MagMax lysis buffer concentrate
(Ambion MagMAX, Applied Biosystems, Foster City, CA, USA) and homogenized.
125 µL of tissue lysate was then mixed with 75 µL of 100% isopropanol; for oral
swab RNA, 500 µL of swab eluate in lysis buffer was extracted on the MagMax
Express-96 deep-well magnetic particle processor using pre-loaded protocols. A
commercially available eukaryotic 18S rRNA primer/probe assay (Applied Biosys-
tems, Grand Island, NY, USA) was used according to manufacturer’s instructions
for an extraction control.
Sequences were obtained using products generated from RT-PCR for MARV
VP35 (Round 1: MBGVP35-F1: GCTTACTTAAATGAGCATGG, MBGVP35-R1:
AGIGCCCGIGTTTCACC; Round 2: MBGVP35-F3: CAAATCTTTCAGCTAA
GG, MBGVP35-R2: TCAGATGAATAIACACAIACCCA) and NP amplicons
(Round 1: MBG704F1+: GTAAAYTTGGTGACAGGTCATG, MBG1248R1-: TCT
CGTTTCTGGCTGAGG; Round 2: MBG719F2+: GGTCATGATGCCTATGACA
GTATCAT; MBG1230R2-: ACGGCIAGTGTCTGACTGTGTG)5,18. For the first
round of PCR, 10 µL of extracted RNA was used. The second round of PCR used 7
µL of the first round PCR reaction. PCR amplicons were analyzed on 2% E-gel.
PCR reactions were purified using Ampure beads and quantitated using Qbit
dsDNA HS Assay Kit on a Qubit 3.0 fluorimeter. The MinION platform was used
with R9 flow cells (FLO-MIN107) and the 1D Barcoded ligation sequencing kit (1D
SQK-LSK108 with the EXP-NBD103 Native Barcoding kit 1D) for sequencing of
amplicons. Sequencing libraries were constructed and performed according to
manufacturer’s instructions. Base calling was performed using ONT Albacore
sequencing pipeline software (version 2.1.10). Reads were mapped to the reference
genome by means of bwa mem using the -x ont2d flag. Reads were then converted
to BAM format using SAMtools view. SAMtools was then used to sort the aligned
BAM files. Consensus sequences were obtained using alignment-base consensus
generation in Geneious (version 11.1.4). Each consensus sequence was manually
reviewed and edited for base calling errors (specifically in homopolymer regions).
Primer sequences used to generate the amplicon were manually trimmed.
Bats captured at Kakoya and Koema Caves were processed at the University of
Makeni. Samples were then shipped to UC Davis where total RNA was extracted
using Direct-Zol RNA columns (Zymo Research Corp), and cDNA prepared using
Superscript III (Invitrogen). Samples were analyzed using a nested filovirus family
level consensus PCR (cPCR) targeting a 680 bp fragment of the filovirus L gene11
(Round 1: Filo-MOD-FWD: TITTYTCHVTICAAAAICAYTGGG, FiloL.conR: AC
CATCATRTTRCTIGGRAAKGCTTT; Round 2: Filo-MOD-FWD: TITTYTCHV
TICAAAAICAYTGGG, Filo-MOD-RVS: GCYTCISMIAIIGTTTGIACATT), an
Ebolavirus genus level cPCR targeting a 187 bp fragment of the NP gene47 (Round
1: SudZaiNP1(+): GAGACAACGGAAGCTAATGC, SudZaiNP1(−): AACGGAA
GATCACCATCATG; Round 2: SudZaiNP2(+): GGTCAGTTTCTATCCTTTGC,
SudZaiNP2(−): CATGTGTCCAACTGATTGCC), a RT-PCR specific for Ebola
virus (EBOV) virus targeting the L-gene48 (EBOV FWD:AACTGATTTAGAGA
AATACAATCTTGC, EBOV RVS: AATGCATCCAATTAAAAACATTC, Probe 1:
FAM-ATTGCAACCGTTGCTATGGT-MGB, Probe 2: FAM-TAGAATATTGTA
ACCGTTGCT-MGB) and a RT-PCR specific for the BOMV virus, targeting the
L-gene11 (Filo_UCD_qFor: TCTCGACGAAGGTCATTAGCGA, Filo_UCD_qRev:
TTGCTCTGGTACTCGCTTGGT, Filo_UCD_probe: FAM-TGCTGGGATGCT
GTCTTTGAGCCT-BHQ). Samples were analyzed for MARV using qRT-PCR
targeting the VP35 gene. Bands of the expected size were excised from 1% agarose
and purified using the Qiaquick kit (Qiagen Inc.). Purified PCR products were
cloned (pCR4-TOPO vector; Invitrogen Corp.) and sequenced (ABI 3730 Capillary
Electrophoresis Genetic Analyzer; Applied Biosystems, Inc., Foster City, CA).
Libraries for genome sequencing were generated with the Kapa Hyper Library kit
(Kapabiosystems, Roche)32 and with VirCapSeq-VERT33, and sequenced on the
Illumina Miseq platform.
For each of the qRT-PCR positive bats from Kasewe, RNA was also purified
using Tri-pure reagent (Invitrogen) and the Direct-Zol RNA Miniprep Plus kit
(Zymo Research). NP and VP35 PCR products were obtained and sequenced on
the SeqStudio Genetic Analyzer (Thermofisher Scientific).
RNA from the virus isolates was obtained and purified as described above and
then used to perform whole genome sequencing on the MiSeq (Illumina). DNA
sequencing libraries were constructed using the NEBNext rRNA Depletion kit
(Human/Mouse/Rat) #E6310 and NEBNext Ultra II RNA Library Prep Kit for
Illumina” #E7335. Indexed libraries generated from pooled liver and spleen (Liv/
Spl) of bats 960 and 968, as well as axillary lymph node (LN) from bat 960 were
pooled and run on the same flowcell using the MiSeq v2 reagent kit. Libraries from
bat 1000 Liv/Spl were run on a separate flowcell.
Phylogenetic analysis. Sequences from the NP and VP35 genes were concatenated
and a multiple sequence alignment was generated using the Clustal Omega pro-
gram49. A maximum likelihood phylogeny was constructed using the best-fit
nucleotide substitution model (GTR+G) in PhyML 3.050,51.
The reads from the virus isolates were mapped to the Angola 1379c reference
strain (GenBank No.: DQ447653), and a consensus sequence was obtained for each
using Geneious v 11.1.2. The consensus sequences were then aligned with all other
MARV full-length sequences using the Clustal Omega program. A maximum
likelihood phylogeny was constructed as described above using the best-fit
nucleotide substitution model (GTR+I+G).
Virus isolation and immunofluorescence assay. All virus isolations were per-
formed at the CDC under biosafety level 4 conditions. Tissue homogenates were
placed into 500 µL DMEM/fungizone/penstrep (100 units/mL penicillin; 100 µg/
mL streptomycin; 2.50 µg/mL amphotericin B; Life Technologies) with 2% fetal
calf serum14. The entire eluate was used to inoculate Vero-E6 cells (American
Type Culture Collection, CRL-1586; mycoplasma-free) in 25 cm2 flasks for 1 h
at 37 °C and 5% CO2. Maintenance media (DMEM containing 2% fetal bovine
serum, 100 units/mL penicillin, and 100 µg/mL streptomycin) was then added to
cultures; cells were monitored for 14 days with a media change on day 7.
All cultures were tested by immunofluorescence assay for MARV antigen at 7
and 14 DPI14. Immunofluorescence assay spot slides prepared from inoculated
Vero E6 cells were fixed in acetone and then gamma-irradiated. After being
incubated with a 1:100 dilution of rabbit anti-MARV polyclonal (in-house) or
normal rabbit serum (negative control; in-house) for 30 min at 37 °C, rinsed two
times with 1× PBS for 10 min, incubated with a 1:40 dilution of goat anti-rabbit
fluorescein isothiocyanate (Capel-ICN Pharmaceuticals, Aurora, OH, USA) for 30
min at 37 °C, rinsed with 1× PBS for 7 min, stained with Eriochrome Black T (in-
house) for 7 min and rinsed with 1× PBS for 7 min, the slides were observed under
a fluorescence microscope.
Serology. Serum samples were tested at the CDC for the presence of MARV-
specific IgG antibodies by indirect ELISA52. Wells of 96-well ELISA plates were
coated (100 µL) with a 1:2000 dilution of MARV antigen lysate (in-house) and
corresponding wells were coated with an equivalent dilution of uninfected control
lysate (in-house). After incubation overnight at 4 °C, the plates were washed with
PBS containing 0.1% Tween-20 (PBS-T) and 100 µL of serum diluent (PBS con-
taining 5% skim milk and 0.1% tween-20) was added to each well of the plate. After
10 min, 33 µL of a 21:521 dilution of gamma-irradiated bat serum pre-diluted in
masterplate diluent (PBS containing 5% skim milk powder, 0.5% tween-20 and 1%
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thimerosal) was added to the first well of the plate and four-fold serial dilutions
were performed. Final bat serum concentrations were 1:100, 1:400, 1:1600, and
1:6400. Following a 1 h incubation at 37 °C, the plates were washed with PBS-T and
100 µL of a 1:11,000 dilution of goat anti-bat IgG conjugated to horseradish per-
oxidase (Bethyl Laboratories, Montgomery, TX, USA) in serum diluent was added
to the plates. The manufacturer notes that this antibody reacts specifically with bat
IgG and with light chains common to other immunoglobulins. After incubation for
1 h at 37 °C, the plates were washed with PBS-T, 100 µL of the Two-Component
ABTS Peroxidase System (KPL, Gaithersburg, MD, USA) was added, and the plates
were allowed to incubate for 30 min at 37 °C. The plates were then read on a
microplate spectrophotometer set at 410 nm. The optical density (OD) values of
each four-fold serial dilution were visually inspected to ensure linearity. To negate
non-specific background reactivity, adjusted OD values were calculated by sub-
tracting the ODs at each four-fold dilution of wells coated with uninfected control
antigen lysate from ODs at corresponding wells coated with MARV antigen lysate.
The adjusted sum OD value was determined by summing the adjusted OD values
at each four-fold serial dilution. A conservative threshold for MARV seropositivity
of 0.92 was applied52.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that all data supporting the findings of this study are available within
the article and its supplementary information files, or from the authors upon request.
Genbank accession numbers for the Sierra Leone NP and VP35 sequences for all Kasbat
SL 2017 and Kasbat SL 2018 sequences are as follows: MN193419—MN193431. Genbank
accession numbers for the Sierra Leone full genome sequences for all Kasbat SL 2017 and
Kasbat SL 2018 sequences are as follows: MN187403—MN187406. Genbank accession
numbers for the SLAB3960Kakbat SL 2017 and SLAB410Koebat SL 2017 are MN258361
—MN258362.
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